This reduction in endocytosis has been observed to retain Fas receptors across multiple cancer cell lines without altering normal cells, enhancing sensitivity to the soluble Fas ligand and inducing cell death in two-dimensional culture, organoids, and in vivo models [12]. This evidence concerns the gene FASLG and cancer.